Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases. Its Hematology products include ADVATE (Antihemophilic Factor (Recombinant)), ADYNOVATE/ADYNOVI (Antihemophilic Factor (Recombinant), PEGylated)), RIXUBIS (Coagulation Factor IX (Recombinant)), VONVENDI (von Willebrand factor (Recombinant)) and FEIBA (Anti-Inhibitor Coagulant Complex). Its Genetic Diseases products include CINRYZE (C1 esterase inhibitor (human)), FIRAZYR (icatibant), ELAPRASE (idursulfase), REPLAGAL (agalsidase alfa) and VPRIV (velaglucerase alfa).
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: LON:SHP
- CUSIP: N/A
- Web: N/A
- Market Cap: £43.2 billion
- Outstanding Shares: 904,099,000
- 50 Day Moving Avg: GBX 4,636.64
- 200 Day Moving Avg: GBX 4,661.74
- 52 Week Range: GBX 2,707.19 - GBX 5,377
Sales & Book Value:
- Trailing P/E Ratio: 147.03
- P/E Growth: 0.93
- Annual Revenue: £13.26 billion
- Price / Sales: 3.26
- Book Value: GBX 32.89 per share
- Price / Book: 1.45
- Average Volume: 2.27 million shs.
Frequently Asked Questions for Shire PLC (LON:SHP)
What is Shire PLC's stock symbol?
Shire PLC trades on the London Stock Exchange (LON) under the ticker symbol "SHP."
How often does Shire PLC pay dividends? What is the dividend yield for Shire PLC?
Shire PLC announced a dividend on Thursday, February 16th. Investors of record on Thursday, March 9th will be given a dividend of GBX 20.64 per share on Tuesday, April 25th. This represents a dividend yield of 0.43%. The ex-dividend date is Thursday, March 9th. This is a positive change from Shire PLC's previous dividend of $3.51. The official announcement can be accessed at this link. View Shire PLC's Dividend History.
When will Shire PLC make its next earnings announcement?
Where is Shire PLC's stock going? Where will Shire PLC's stock price be in 2017?
18 equities research analysts have issued 12 month price targets for Shire PLC's stock. Their predictions range from GBX 4,450 to GBX 6,970. On average, they expect Shire PLC's stock price to reach GBX 6,108.38 in the next year. View Analyst Ratings for Shire PLC.
Who are some of Shire PLC's key competitors?
Some companies that are related to Shire PLC include GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), BHP Billiton plc (BLT), Vodafone Group plc (VOD), Diageo plc (DGE), Lloyds Banking Group PLC (LLOY), Rio Tinto plc (RIO), Barclays PLC (BARC), Reckitt Benckiser Group Plc (RB), Prudential plc (PRU), Glencore PLC (GLEN), National Grid plc (NG), Redt Energy PLC (CCE), Carnival plc (CCL), Imperial Brands PLC (IMB), Relx PLC (REL), Royal Bank of Scotland Group plc (RBS) and COMPAGNIE DE SAINT-GOBAIN COMPAGNIE DE ST-GOBAIN (COD).
How do I buy Shire PLC stock?
Shares of Shire PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
How much does a share of Shire PLC stock cost?
One share of Shire PLC stock can currently be purchased for approximately GBX 4,778.50.
Consensus Ratings for Shire PLC (LON:SHP) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||1 Sell Rating, 17 Buy Ratings|
|Consensus Rating:||Buy (Score: 2.89)|
|Consensus Price Target: ||GBX 6,108.38|
Analysts' Ratings History for Shire PLC (LON:SHP)
(Data available from 5/25/2015 forward)
|5/19/2017||HSBC Holdings plc||Downgrade||Reduce||GBX 4,550 -> GBX 4,450|
|5/19/2017||Barclays PLC||Reiterated Rating||Overweight||GBX 6,500|
|5/19/2017||Deutsche Bank AG||Reiterated Rating||Buy||GBX 6,100|
|5/19/2017||JPMorgan Chase & Co.||Reiterated Rating||Overweight||GBX 6,000|
|5/17/2017||Citigroup Inc||Reiterated Rating||Buy||GBX 6,500|
|5/11/2017||Berenberg Bank||Reiterated Rating||Buy||GBX 5,900|
|5/3/2017||Credit Suisse Group AG||Reiterated Rating||Outperform||GBX 5,400|
|5/3/2017||Goldman Sachs Group Inc||Reiterated Rating||Buy||GBX 6,800|
|5/3/2017||Liberum Capital||Reiterated Rating||Buy||GBX 5,500|
|5/3/2017||Jefferies Group LLC||Reiterated Rating||Buy||GBX 6,400|
|5/2/2017||Shore Capital||Reiterated Rating||Buy|
|4/27/2017||Royal Bank of Canada||Reiterated Rating||Outperform|
|4/3/2017||BNP Paribas||Reiterated Rating||Outperform||GBX 5,900|
|3/23/2017||Societe Generale||Reiterated Rating||Buy||GBX 6,200|
|1/9/2017||Bryan, Garnier & Co||Reiterated Rating||Buy||GBX 6,800|
|11/7/2016||AlphaValue||Reiterated Rating||Buy||GBX 6,714|
|11/3/2016||Bank of America Corp||Reiterated Rating||Buy||GBX 6,970|
|6/3/2016||Morgan Stanley||Reiterated Rating||Overweight||GBX 5,600|
|3/15/2016||Sanford C. Bernstein||Reiterated Rating||Outperform||GBX 5,000|
|1/12/2016||S&P Equity Research||Reiterated Rating||Buy|
|11/3/2015||Kepler Capital Markets||Lower Price Target||Buy||GBX 6,000 -> GBX 5,900|
Earnings History for Shire PLC (LON:SHP)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Shire PLC (LON:SHP)
Current Year EPS Consensus Estimate: $5.05 EPS
Dividend History by Quarter for Shire PLC (LON:SHP)
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Insider Trading and Institutional Ownership History for Shire PLC (LON:SHP)Insider Trades by Quarter for Shire PLC (LON:SHP)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|3/31/2017||William Burns||Insider||Buy||136||GBX 4,742||£6,449.12|
|12/16/2016||Olivier Bohuon||Insider||Buy||141||GBX 4,528||£6,384.48|
|9/30/2016||Dominic Blakemore||Insider||Buy||133||GBX 5,010||£6,663.30|
|9/30/2015||Blakemore ,Dominic||Insider||Buy||129||GBX 4,498||£5,802.42|
|6/30/2015||Kappler,David J||Insider||Buy||126||GBX 51.05||GBX 6,432.30|
|3/31/2015||Susan Kilsby||Insider||Buy||375||GBX 5,327||£19,976.25|
|12/19/2014||Steven Gillis||Insider||Buy||228||GBX 4,654||£10,611.12|
|10/30/2014||Steven Gillis||Insider||Buy||381||GBX 4,098||£15,613.38|
Headline Trends for Shire PLC (LON:SHP)
Latest Headlines for Shire PLC (LON:SHP)
Shire PLC (SHP) Chart for Thursday, May, 25, 2017